Rituximab maintenance significantly prolongs progression‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation
Gespeichert in:
| Veröffentlicht in: | American journal of hematology 2019-02, Vol.94 (2), p.E50-E53 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | E53 |
|---|---|
| container_issue | 2 |
| container_start_page | E50 |
| container_title | American journal of hematology |
| container_volume | 94 |
| creator | Klener, Pavel Salek, David Pytlik, Robert Mocikova, Heidi Forsterova, Kristina Blahovcova, Petra Campr, Vit Prochazka, Vit Obr, Ales Jaksa, Radek Kuntscherova, Jana Boudová, Ludmila Kodet, Roman Janikova, Andrea Trneny, Marek |
| description | |
| doi_str_mv | 10.1002/ajh.25362 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2138041933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2138041933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3882-f5027c9e27835b6d2a268a3398c2a60d5ce7a628e057caa25791819aaf32fe953</originalsourceid><addsrcrecordid>eNp1kUuOEzEQhi0EYsLAggsgS2xgkRk_-uXlKAIGFEBCsG5V3NUdR2472O4J2XEELsYlOAnO9MACiZVL8ldf_dJPyFPOLjhj4hJ22wtRykrcIwvOVLVsqlLcJwsmK55nps7Ioxh3jHFeNOwhOZOsqAte8wX5-cmk6ZsZYUNHMC6hA6eRRjM40xsNLtkj3QdvvRviaRgCxmi8-_X9Rx8wk1O4MTdgqe_pHpJBlyI9mLSlDg95tzMwOB-xy_4sQ6rRWmqP437rR6ApIKT8ebuRtkg_-NAZTd-v1uJ0LnntLQXXUZhSTjH4KdKYcJw9KYCLe5vN-bR3j8mDHmzEJ3fvOfny-tXn1fVy_fHN29XVeqll04hlXzJRa4WibmS5qToBompAStVoARXrSo01VKJBVtYaQJS14g1XAL0UPapSnpMXszcn_DphTO1o4ikQOMwBW8FlwwqupMzo83_QnZ-Cy-kyVRWqZKVQmXo5Uzr4GAP27T7kUsKx5aw9ddzmjtvbjjP77M44bUbs_pJ_Ss3A5QwcjMXj_03t1bvrWfkbzZG2xg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2164950529</pqid></control><display><type>article</type><title>Rituximab maintenance significantly prolongs progression‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation</title><source>Wiley Journals</source><source>Wiley-Blackwell Backfiles (Open access)</source><source>EZB Electronic Journals Library</source><creator>Klener, Pavel ; Salek, David ; Pytlik, Robert ; Mocikova, Heidi ; Forsterova, Kristina ; Blahovcova, Petra ; Campr, Vit ; Prochazka, Vit ; Obr, Ales ; Jaksa, Radek ; Kuntscherova, Jana ; Boudová, Ludmila ; Kodet, Roman ; Janikova, Andrea ; Trneny, Marek</creator><creatorcontrib>Klener, Pavel ; Salek, David ; Pytlik, Robert ; Mocikova, Heidi ; Forsterova, Kristina ; Blahovcova, Petra ; Campr, Vit ; Prochazka, Vit ; Obr, Ales ; Jaksa, Radek ; Kuntscherova, Jana ; Boudová, Ludmila ; Kodet, Roman ; Janikova, Andrea ; Trneny, Marek</creatorcontrib><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.25362</identifier><identifier>PMID: 30474171</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Autografts ; Hematology ; Immunotherapy ; Mantle cell lymphoma ; Monoclonal antibodies ; Rituximab ; Stem cell transplantation ; Targeted cancer therapy</subject><ispartof>American journal of hematology, 2019-02, Vol.94 (2), p.E50-E53</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><rights>2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3882-f5027c9e27835b6d2a268a3398c2a60d5ce7a628e057caa25791819aaf32fe953</citedby><cites>FETCH-LOGICAL-c3882-f5027c9e27835b6d2a268a3398c2a60d5ce7a628e057caa25791819aaf32fe953</cites><orcidid>0000-0001-7786-9378</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.25362$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.25362$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30474171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Klener, Pavel</creatorcontrib><creatorcontrib>Salek, David</creatorcontrib><creatorcontrib>Pytlik, Robert</creatorcontrib><creatorcontrib>Mocikova, Heidi</creatorcontrib><creatorcontrib>Forsterova, Kristina</creatorcontrib><creatorcontrib>Blahovcova, Petra</creatorcontrib><creatorcontrib>Campr, Vit</creatorcontrib><creatorcontrib>Prochazka, Vit</creatorcontrib><creatorcontrib>Obr, Ales</creatorcontrib><creatorcontrib>Jaksa, Radek</creatorcontrib><creatorcontrib>Kuntscherova, Jana</creatorcontrib><creatorcontrib>Boudová, Ludmila</creatorcontrib><creatorcontrib>Kodet, Roman</creatorcontrib><creatorcontrib>Janikova, Andrea</creatorcontrib><creatorcontrib>Trneny, Marek</creatorcontrib><title>Rituximab maintenance significantly prolongs progression‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><subject>Autografts</subject><subject>Hematology</subject><subject>Immunotherapy</subject><subject>Mantle cell lymphoma</subject><subject>Monoclonal antibodies</subject><subject>Rituximab</subject><subject>Stem cell transplantation</subject><subject>Targeted cancer therapy</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kUuOEzEQhi0EYsLAggsgS2xgkRk_-uXlKAIGFEBCsG5V3NUdR2472O4J2XEELsYlOAnO9MACiZVL8ldf_dJPyFPOLjhj4hJ22wtRykrcIwvOVLVsqlLcJwsmK55nps7Ioxh3jHFeNOwhOZOsqAte8wX5-cmk6ZsZYUNHMC6hA6eRRjM40xsNLtkj3QdvvRviaRgCxmi8-_X9Rx8wk1O4MTdgqe_pHpJBlyI9mLSlDg95tzMwOB-xy_4sQ6rRWmqP437rR6ApIKT8ebuRtkg_-NAZTd-v1uJ0LnntLQXXUZhSTjH4KdKYcJw9KYCLe5vN-bR3j8mDHmzEJ3fvOfny-tXn1fVy_fHN29XVeqll04hlXzJRa4WibmS5qToBompAStVoARXrSo01VKJBVtYaQJS14g1XAL0UPapSnpMXszcn_DphTO1o4ikQOMwBW8FlwwqupMzo83_QnZ-Cy-kyVRWqZKVQmXo5Uzr4GAP27T7kUsKx5aw9ddzmjtvbjjP77M44bUbs_pJ_Ss3A5QwcjMXj_03t1bvrWfkbzZG2xg</recordid><startdate>201902</startdate><enddate>201902</enddate><creator>Klener, Pavel</creator><creator>Salek, David</creator><creator>Pytlik, Robert</creator><creator>Mocikova, Heidi</creator><creator>Forsterova, Kristina</creator><creator>Blahovcova, Petra</creator><creator>Campr, Vit</creator><creator>Prochazka, Vit</creator><creator>Obr, Ales</creator><creator>Jaksa, Radek</creator><creator>Kuntscherova, Jana</creator><creator>Boudová, Ludmila</creator><creator>Kodet, Roman</creator><creator>Janikova, Andrea</creator><creator>Trneny, Marek</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7786-9378</orcidid></search><sort><creationdate>201902</creationdate><title>Rituximab maintenance significantly prolongs progression‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation</title><author>Klener, Pavel ; Salek, David ; Pytlik, Robert ; Mocikova, Heidi ; Forsterova, Kristina ; Blahovcova, Petra ; Campr, Vit ; Prochazka, Vit ; Obr, Ales ; Jaksa, Radek ; Kuntscherova, Jana ; Boudová, Ludmila ; Kodet, Roman ; Janikova, Andrea ; Trneny, Marek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3882-f5027c9e27835b6d2a268a3398c2a60d5ce7a628e057caa25791819aaf32fe953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Autografts</topic><topic>Hematology</topic><topic>Immunotherapy</topic><topic>Mantle cell lymphoma</topic><topic>Monoclonal antibodies</topic><topic>Rituximab</topic><topic>Stem cell transplantation</topic><topic>Targeted cancer therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klener, Pavel</creatorcontrib><creatorcontrib>Salek, David</creatorcontrib><creatorcontrib>Pytlik, Robert</creatorcontrib><creatorcontrib>Mocikova, Heidi</creatorcontrib><creatorcontrib>Forsterova, Kristina</creatorcontrib><creatorcontrib>Blahovcova, Petra</creatorcontrib><creatorcontrib>Campr, Vit</creatorcontrib><creatorcontrib>Prochazka, Vit</creatorcontrib><creatorcontrib>Obr, Ales</creatorcontrib><creatorcontrib>Jaksa, Radek</creatorcontrib><creatorcontrib>Kuntscherova, Jana</creatorcontrib><creatorcontrib>Boudová, Ludmila</creatorcontrib><creatorcontrib>Kodet, Roman</creatorcontrib><creatorcontrib>Janikova, Andrea</creatorcontrib><creatorcontrib>Trneny, Marek</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klener, Pavel</au><au>Salek, David</au><au>Pytlik, Robert</au><au>Mocikova, Heidi</au><au>Forsterova, Kristina</au><au>Blahovcova, Petra</au><au>Campr, Vit</au><au>Prochazka, Vit</au><au>Obr, Ales</au><au>Jaksa, Radek</au><au>Kuntscherova, Jana</au><au>Boudová, Ludmila</au><au>Kodet, Roman</au><au>Janikova, Andrea</au><au>Trneny, Marek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rituximab maintenance significantly prolongs progression‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2019-02</date><risdate>2019</risdate><volume>94</volume><issue>2</issue><spage>E50</spage><epage>E53</epage><pages>E50-E53</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30474171</pmid><doi>10.1002/ajh.25362</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-7786-9378</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0361-8609 |
| ispartof | American journal of hematology, 2019-02, Vol.94 (2), p.E50-E53 |
| issn | 0361-8609 1096-8652 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2138041933 |
| source | Wiley Journals; Wiley-Blackwell Backfiles (Open access); EZB Electronic Journals Library |
| subjects | Autografts Hematology Immunotherapy Mantle cell lymphoma Monoclonal antibodies Rituximab Stem cell transplantation Targeted cancer therapy |
| title | Rituximab maintenance significantly prolongs progression‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T11%3A30%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rituximab%20maintenance%20significantly%20prolongs%20progression%E2%80%90free%20survival%20of%20patients%20with%20newly%20diagnosed%20mantle%20cell%20lymphoma%20treated%20with%20the%20Nordic%20MCL2%20protocol%20and%20autologous%20stem%20cell%20transplantation&rft.jtitle=American%20journal%20of%20hematology&rft.au=Klener,%20Pavel&rft.date=2019-02&rft.volume=94&rft.issue=2&rft.spage=E50&rft.epage=E53&rft.pages=E50-E53&rft.issn=0361-8609&rft.eissn=1096-8652&rft_id=info:doi/10.1002/ajh.25362&rft_dat=%3Cproquest_cross%3E2138041933%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2164950529&rft_id=info:pmid/30474171&rfr_iscdi=true |